9 research outputs found
Glycaemic patterns in healthy elderly individuals and in those with impaired glucose metabolism - exploring the relationship with nonglycaemic variables.
OBJECTIVE
The SENIORLABOR study data were explored (i) to examine the evolution during senescence of the differences between measured glycated haemoglobin (HbA1c) values and the values predicted by using regression to extrapolate from measured fructosamine levels; (ii) to scrutinise the relationship between the glycation gap and insulin resistance using a homeostasis model assessment, and between the glycation gap and a low-grade inflammation marker (C-reactive protein serum concentration); and (iii) to investigate the glycation gap ranges in relation to triglyceride levels and kidney function.
SUBJECTS AND METHODS
A total of 1432 Swiss individuals aged >60 years and classified as healthy (547), prediabetic (701) or diabetic (184) based on their fasting plasma glucose and HbA1c values were included in the study. The glycation gap was evaluated and assigned to one of four categories: <−0.5; −0.5 to <0.0; 0.0 to ≤0.5; >0.5.
RESULTS
In healthy and prediabetic participants, the homeostasis model assessment for estimation of insulin resistance (p <0.01), high-sensitivity C-reactive protein (p <0.001) and triglyceride (p = 0.02) values tended to increase with increasing glycation gap category and were highest in the glycation gap category >0.5. Homeostasis model assessment for estimation of insulin resistance, high-sensitivity C-reactive protein and triglyceride levels tended to increase with increasing glycation gap category and were highest in the glycation gap category >0.5. Significant differences (p <0.01) between glycation gap categories were seen among different high-sensitivity C-reactive protein concentration groups. Interestingly, in diabetic participants, homeostasis model assessment for estimation of insulin resistance values, triglyceride concentrations and estimation of glomerular filtration values all decreased with decreasing glycation gap category. In the group of participants with a glycation gap >0.5, high-sensitivity C-reactive protein values tended to increase with increasing glycation gap, whereas for participants with type 2 diabetes and in the glycation gap group >0.5, high-sensitivity C-reactive protein levels tended to decrease as the glycation gap increased. The percentage of participants with type 2 diabetes mellitus increased from 2% in the glycation gap category <−0.5 to 76% in the glycation gap category >0.5. In contrast, the percentage of healthy participants fell from 85% to 7%.
CONCLUSION
This is the first time that a direct comparison of healthy, prediabetic and diabetic participants, all assessed under identical conditions and using identical methodology, has clearly demonstrated a different glycation gap pattern. Thus, we contribute evidence that the glycation gap might be of interest in the care of diabetic patients and their prophylaxis, while acknowledging that more studies are needed to confirm our findings. (Trial registration number ISRCTN53778569)
Reference Intervals for Platelet Counts in the Elderly: Results from the Prospective SENIORLAB Study.
Currently, age- and sex-independent reference limits (RLs) are frequently used to interpret platelet counts in seniors. We aimed to define and validate reference intervals (RIs) for platelet counts within the framework of the prospective SENIORLAB study. Subjectively healthy Swiss individuals aged 60 years and older were prospectively included and followed for morbidity and mortality. Participants who had circumstances known to affect platelet counts were excluded. The obtained RIs were validated with indirect statistical methods. Frequencies of abnormal platelet counts in a population-based setting, including 41.5% of the entire age-specific population of the Principality of Liechtenstein, were compared by using age- and sex-independent RIs and the RLs obtained in the present study. For males (n = 542), 95% RIs for platelet counts were defined as follows: 150-300 × 109/L (60-69 years); 130-300 × 109/L (70-79 years); and 120-300 × 109/L (80 years and above). For females (n = 661), the consolidated age-independent 95% RI was 165-355 × 109/L. These RI values were validated by indirect RI determination of 51,687 (30,392 female/21,295 male) patients of the same age. Age- and sex-independent RIs exhibited imbalanced frequencies of abnormal platelet counts between the two sexes, which were corrected by introducing age- and sex-specific RLs. In conclusion, females have higher platelet counts than males. Whereas the upper RL for males remains constant, the lower RL decreases with age. We propose to abandon the practice of employing sex- and age-independent RL for platelet counts in the elderly
Hepatitis C virus epidemiology and prevention in Polish and Swiss population – similar and contrasting experiences
Objective
The aim of the study was to review available data on HCV in Poland and Switzerland, in order to compare the two European countries with respect to epidemiological situation and efficiency of the response systems.
Material and Methods
A search of registries, published and grey literature was performed to assemble data on prevalence, rate of detection of new cases, identified risk factors for transmission, mortality due to HCV, prevalence of HCC and the consequent liver transplantations, as well as data on treatment in Poland and Switzerland.
Results
Overall, the prevalence of anti-HCV antibodies was similar, not exceeding 1%. However, the major transmission routes of HCV infections were different: medical procedures in Poland and drug injections in Switzerland. By combining the available information it was also possible to demonstrate important differences in efficiency of the response systems. There was approximately 1 new diagnosis per 100 estimated undiagnosed cases in the population in Poland per year, compared to 6 in Switzerland, and the treatment rate per 100 estimated active infections was 2 and 4, respectively.
Conclusions
Scaling up of the diagnosis and treatment is necessary in both countries; however, the means to achieve this might differ, taking into account the higher concentration of the infections in risk groups in Switzerland than in Poland
Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study.
BACKGROUND
Vitamin D and the components of humoral immunity play important roles in human health. Older people have lower 25-hydroxyvitamin D (25(OH)D) serum levels than younger adults. We aimed to determine the levels of 25(OH)D serum concentrations in healthy senior citizens and to study their relationship to the levels of components of humoral immunity.
METHODS
A total of 1,470 healthy Swiss men and women, 60 years or older, were recruited for this study. A total of 179 subjects dropped out of the study because of elevated serum concentrations of C-reactive protein. Fasting blood sera were analyzed for 25(OH)D with the high-performance liquid chromatography (HPLC) and for parathyroid hormone (PTH), immunoglobulins and complement C4 and C3 concentrations with immunoassays. The percentage of participants in each of the four 25(OH)D deficiency groups--severely deficient (=30 ng/ml)--were statistically compared. The relationship of the major components of the humoral system and age with 25(OH)D levels was also assessed.
RESULTS
About 66% of the subjects had insufficient levels of 25(OH)D. Normal levels of 25(OH)D were found in 26.1% of the subjects of which 21% were males and 30.5% were females (total study population). Severely deficient levels of 25(OH)D were found in 7.98% of the total study population. Low levels of 25(OH)D were positively associated with IgG2 (P = 0.01) and with C4 (P = 0.02), yet were inversely related to levels of IgG1 and IgA (P < 0.05) and C3 (P = 0.01). Serum levels of total IgA, IgG, IgG2 and IgG4 peaked together with 25(OH)D during late summer.
CONCLUSIONS
Approximately two-thirds of the healthy, older Swiss population presented with Vitamin D insufficiency. The incremental shift in IgA and C3 levels might not necessarily reflect a deranged humoral immune defense; however, given the high prevalence of vitamin D deficiency, the importance of this condition in humoral immunity will be worth looking at more closely. This study supports the role of vitamin D in the competent immune system
Epidemiological characteristics and clinical manifestations of hepatitis E virus infection in Bulgaria: A report on 20 patients
Introduction. Hepatitis E is one of the leading clinical manifestations of
acute viral hepatitis in developing countries. In industrialized countries,
during the past several years, sporadic “autochthonous” cases of HEV
infection have been increased. Objective. The aim of this study was to
analyze the epidemiological, clinical and laboratory features of HEV
infection among patients hospitalized at the Department of Infectious
Diseases in Military Medical Academy, Sofia, Bulgaria. Methods. A
retrospective study of 806 cases of acute viral hepatitis was performed at
the Department of Infectious Diseases in Military Medical Academy, Sofia,
Bulgaria, between December 2004 and September 2012. The etiological diagnosis
was established by ELISA. The statistical analysis was performed using Excel
2007 (Microsoft, Redmond, Washington, USA) and SPSS Statistics 19.0 (IBM
Corp., Armonk, New York, USA). Results. Specific reaction to anti-HEV-IgM and
anti-HEV-IgG antibodies were detected in 20 (2.48%) of 806 patients. The most
observed clinical presentations were jaundice (85%), fatigue (85%), anorexia
(65%), abdominal discomfort (55%) and fever (40%). The mean values of
aspartate transaminase and alanine transaminase were 521 IU/l and 881 IU/l,
respectively. The cholestasis was slight, marked with mean values of
gamma-glutamyl transferase and alkaline phosphatase, respectively 418 IU/l
and 486 IU/l. Conclusion. We report twenty autochthonous sporadic cases of
acute infection with HEV. The zoonotic etiology of the virus as well as the
foodborne transmission of the infection is discussed. We found that aging and
pre-existing underlying diseases are risk factors for a severe course of the
HEV infection
Epidemiological characteristics and clinical manifestations of hepatitis E virus infection in Bulgaria: A report on 20 patients
Introduction. Hepatitis E is one of the leading clinical manifestations of
acute viral hepatitis in developing countries. In industrialized countries,
during the past several years, sporadic “autochthonous” cases of HEV
infection have been increased. Objective. The aim of this study was to
analyze the epidemiological, clinical and laboratory features of HEV
infection among patients hospitalized at the Department of Infectious
Diseases in Military Medical Academy, Sofia, Bulgaria. Methods. A
retrospective study of 806 cases of acute viral hepatitis was performed at
the Department of Infectious Diseases in Military Medical Academy, Sofia,
Bulgaria, between December 2004 and September 2012. The etiological diagnosis
was established by ELISA. The statistical analysis was performed using Excel
2007 (Microsoft, Redmond, Washington, USA) and SPSS Statistics 19.0 (IBM
Corp., Armonk, New York, USA). Results. Specific reaction to anti-HEV-IgM and
anti-HEV-IgG antibodies were detected in 20 (2.48%) of 806 patients. The most
observed clinical presentations were jaundice (85%), fatigue (85%), anorexia
(65%), abdominal discomfort (55%) and fever (40%). The mean values of
aspartate transaminase and alanine transaminase were 521 IU/l and 881 IU/l,
respectively. The cholestasis was slight, marked with mean values of
gamma-glutamyl transferase and alkaline phosphatase, respectively 418 IU/l
and 486 IU/l. Conclusion. We report twenty autochthonous sporadic cases of
acute infection with HEV. The zoonotic etiology of the virus as well as the
foodborne transmission of the infection is discussed. We found that aging and
pre-existing underlying diseases are risk factors for a severe course of the
HEV infection
Hepatitis C virus epidemiology and prevention in Polish and Swiss population – similar and contrasting experiences
Objective
The aim of the study was to review available data on HCV in Poland and Switzerland, in order to compare the two European countries with respect to epidemiological situation and efficiency of the response systems.
Material and Methods
A search of registries, published and grey literature was performed to assemble data on prevalence, rate of detection of new cases, identified risk factors for transmission, mortality due to HCV, prevalence of HCC and the consequent liver transplantations, as well as data on treatment in Poland and Switzerland.
Results
Overall, the prevalence of anti-HCV antibodies was similar, not exceeding 1%. However, the major transmission routes of HCV infections were different: medical procedures in Poland and drug injections in Switzerland. By combining the available information it was also possible to demonstrate important differences in efficiency of the response systems. There was approximately 1 new diagnosis per 100 estimated undiagnosed cases in the population in Poland per year, compared to 6 in Switzerland, and the treatment rate per 100 estimated active infections was 2 and 4, respectively.
Conclusions
Scaling up of the diagnosis and treatment is necessary in both countries; however, the means to achieve this might differ, taking into account the higher concentration of the infections in risk groups in Switzerland than in Poland